PrimaHealth Credit offers a buy-now, pay-later lending service for elective procedures

The Newport Beach, California-based healthcare lending service PrimaHealth Credit is now pitching point-of-sale lending services for elective medical procedures.

Taking the kinds of financial lending services that have been popularized by companies like Klarna and Affirm, PrimaHealth Credit is bringing them into elective surgical space for things like cataract surgery, orthodontic work, dental care or LASIK.

“For many dental, orthodontics, LASIK, and cataract surgery patients, our BNPL product is a ‘last resort’ – the difference between getting the treatment they need, or not,” said Brendon Kensel, founder and CEO of PrimaHealth Credit, in a statement.

The company expects that patients will pay somewhere between 25% and 50% of the cost of their treatment up front with repayment durations for the loans ranging between two and four months.

Rates for the loans will range from 19.99% to 24.99% APR with average loan sizes coming in at around $1,800 across dental, orthodontics and LASIK, according to the company.

“Until now, when providers couldn’t approve patients for an existing payment plan, they’d either forego providing them care or take them on anyway, exposing themselves to significant liability as they struggle with adequately assessing creditworthiness and properly servicing and collecting loans,” Kensel said.

The program not only handles loan origination for healthcare practices, but handles the back-office tasks for payment and servicing.

“Our goal as a company is to remove barriers to patient acceptance and help people who have the means but not necessarily the credit score to get the quality care that everyone deserves,” Kensel said.

Using the PrimaHealth Credit mobile app, patients can receive instant credit decisions and choose the payment plan that works best for them. The company said the service is currently available in Arizona, California, Florida, Oklahoma, and Texas and will be expanded to all 50 states by 2021.

Leave a Reply

Your email address will not be published. Required fields are marked *